BioAdaptives, Inc. Expands Inventory Bringing Order Fulfillment In-House

LAS VEGAS, NV--(Marketwired - Feb 16, 2016) - BioAdaptives, Inc. (OTCBB: BDPT) announced the completion of a transaction to purchase inventory valued at just under $1,100,000 in retail products. The products include PrimiCell®, PrimiLive®, PrimiTrim™, and Equine Regen® Plus.

In addition, BioAdaptives is securing additional manufacturing capacity to the cover the expected demand for the next two years.

Christopher G. Hall, President of BioAdaptives, said, "By bringing inventory in-house this all stock transaction puts BioAdaptives in a much stronger position to handle rapid order fulfillment as we expand our distribution channels."

About BioAdaptives, Inc.

BioAdaptives, Inc. is a fully reporting, public company trading on the OTC Bulletin Board under the symbol BDPT. The company is engaged in research and development in science-based nutraceutical products for human and animal consumption. The company's focus is to source high quality, unique, raw material worldwide and develop science-based products to improve health and wellness in both humans and animals. BioAdaptives, Inc. owns the rights to a proprietary non-invasive bioelectromagnetic and sonic device for improving individual ingredients, food, beverages, and wellness.

SAFE HARBOR ACT

Forward-Looking Statements: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of BioAdaptives, Inc. and its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond BioAdaptives, Inc.'s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in BioAdaptives, Inc.'s filings with the Securities and Exchange Commission.